1. Home
  2. BATRA vs IDYA Comparison

BATRA vs IDYA Comparison

Compare BATRA & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

N/A

Current Price

$54.10

Market Cap

3.7B

Sector

Industrials

ML Signal

N/A

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$37.59

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BATRA
IDYA
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.6B
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
BATRA
IDYA
Price
$54.10
$37.59
Analyst Decision
Buy
Strong Buy
Analyst Count
2
16
Target Price
$60.00
$52.86
AVG Volume (30 Days)
64.4K
663.8K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
26.00
61.90
EPS
N/A
N/A
Revenue
$732,492,000.00
$218,710,000.00
Revenue This Year
$12.40
N/A
Revenue Next Year
$8.54
$201.05
P/E Ratio
N/A
N/A
Revenue Growth
10.52
3024.43
52 Week Low
$41.50
$24.24
52 Week High
$58.37
$42.68

Technical Indicators

Market Signals
Indicator
BATRA
IDYA
Relative Strength Index (RSI) 43.87 43.85
Support Level $53.62 $35.11
Resistance Level $56.09 $37.82
Average True Range (ATR) 1.12 1.27
MACD -0.19 -0.40
Stochastic Oscillator 18.67 3.63

Price Performance

Historical Comparison
BATRA
IDYA

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: